6/8/2020
Is your Company in our Directory?
CURE Pharmaceutical [OTC: CURR] Expands Highly Valuable Medication Patent Portfolio
6/14/2020
Ø Innovative Medication Development & Enhancement Company.
Ø Patents for Extraction, Concentration & Processing of Specialized Medicinal Compounds.
Ø New Marketing to Mexico in Collaboration with Factoria Bogar Subsidiary.
Ø New Oral Thin Film Products for High Value Erectile Dysfunction Market.
On June 3rd CURE Pharmaceutical (OTC:CURR), an innovative medication development and enhancement company, announced a collaboration with PMI, a subsidiary of Factoria Bogar in Guadalajara, Mexico. PMI will have access to the CURR bio-product platform, CUREform™ for its medication formulation, and become its distribution partner in Mexico for CURR wellness products, such as its vitamin D supplement, sleep and specialized botanical extract products.
The CURR weekly vitamin D supplements provide 50,000 IU of vitamin D3 to reduce the risk of infections. CURR sleep strips contain a soothing blend of melatonin, naturally occurring amino acids and beneficial vitamins that promote fast-acting, balanced sleep patterns for a deep, restful slumber and a rejuvenated awakening.
The PMI collaboration will include several development initiatives with its proprietary prebiotic product from Agave in combination with special botanical extracts that leverage the CURR CUREform™ novel delivery platform for treatment of multiple GI indications. There are patient studies planned for Mexico to improve medication efficacy with CURR extracts and prebiotics.
Ø New Patents Issued on Key Therapeutics for Infectious Diseases
On April 21st CURR announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. The patents represent an expansion of the existing CURR “product by process” patents for obtaining multiple unique concentrates using super critical fluid extraction (SCFE). These include concentrates which have shown promising therapeutic activity in animal studies in areas such as inflammatory bowel disease, cancer and infectious diseases.
Additionally, CURR is granting equipment manufacturers, processing companies and drug developers licenses to its portfolio of issued and pending process and composition patents for isolating specific botanical compounds using an advanced SCFE technology utilizing carbon dioxide as the solvent. While the patents cover the incorporation of extracts into multiple dosage forms, CURR has retained all rights to applying these methods in oral thin films.
The two new CURR patents cover the extraction and purification of specialized plant material, as well as subsequent processing of extracts for medication formulations. This extraction and fractioning of bioactive molecules allows for the integration of molecules into dosage forms.
Ø New Applications in the Multi-Billion Dollar Erectile Dysfunction Market
This news follows up on a CURR announcement of March 17th which detailed the allowance of Chinese Patent No. ZL201480039313.6 regarding the loading of high amounts of active drug on an oral thin film using its proprietary drug delivery systems. This new patent includes the company’s lead product, CUREfilm Blue™, a soluble thin film for oral administration of sildenafil citrate to treat erectile dysfunction (ED) in China.
The ED drug market is expected to reach USD $6.5 billion at a 6% compound annual growth rate by 2025, according to QYResearch. The report points out that the Asia Pacific market will be one of the fastest growing markets for ED medicine. Sildenafil is leading the ED drug market worldwide with more than half of all global sales.
The CURR ED patent covers methods of preparing edible thin films that can deliver high doses of active ingredients that are encapsulated using lipids to form micelles or liposomes. This enables CURR to differentiate its oral thin film product from sildenafil oral soluble films.
For more Information visit the CURR company website at: https://www.curepharmaceutical.com/
###
Other articles and publications:
CURE Pharmaceutical [OTCQB: CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
Mr. Berlent is an accomplished business growth executive with more than 25 years of private and public company experience focused on strategic partnerships.
7/9/2020
$10 Million Financing Completed to Strongly Expand Global Marketing and Drive Revenue Returns.
11/21/2020
CURR Products Fall Into Two Categories: Nutraceuticals (dietary supplements) and Pharmaceutical Medicines
9/4/2020
This certification positions CURE’s manufacturing capabilities at the forefront of quality standards set by the various regulatory agencies.
11/21/2020
Enrollment is expected to be completed by the end of 2021.
12/12/2021
Articles and publications of other companies:
A cost-effective flexible packaging that ensures our Earth will be green tomorrow from Gear Packagin
Gear packaging a known name in the market over a decade continues to be a leader in sustainability and offers high quality flexible packaging by using the eco-friendliest methods available.
12/13/2018
All Natural Kidney Health & Kidney Function Restoration Program is a kidney health reversal program through natural remedies for the patients suffering from kidney problems.
5/29/2019
PTJ CNC Machining is here to use some of the best materials for covering high speed machining services. Some of those materials are titanium and 304-stainless steel.
7/18/2019
YNM is committed to providing high-end technology bed lines and products for customers, and build a solid base and pleasant sleeping atmosphere for every user.
11/27/2018
Who said luxury cannot be casual? Introducing smart joggers and leggings, more elegant and more versatile like never before.
11/27/2018
Rushing Speed is now offering you high-quality CNC routers. The CNC router gives you to simplify working process technology and easily fix working pieces. It reduces the cost of labor also.
11/27/2018
New York
company, product and service directory
company, product and service directory
Business Network 2008-2024
All rights reserved
All rights reserved